PE20030206A1 - Composicion oftalmica - Google Patents
Composicion oftalmicaInfo
- Publication number
- PE20030206A1 PE20030206A1 PE2002000483A PE2002000483A PE20030206A1 PE 20030206 A1 PE20030206 A1 PE 20030206A1 PE 2002000483 A PE2002000483 A PE 2002000483A PE 2002000483 A PE2002000483 A PE 2002000483A PE 20030206 A1 PE20030206 A1 PE 20030206A1
- Authority
- PE
- Peru
- Prior art keywords
- ophthalmic
- mpa
- treatment
- octilphenoxy
- ketotyphene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
QUE COMPRENDE: a)0,005% A 5% DEL PESO TOTAL DE UN FARMACO OFTALMICO SELECCIONADO DE: DICLOFENACO, PREDNISOLONA, CETOTIFENO, ACIDO ASCORBICO, RETINAL, O SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS; b)0,05% A 10% DE UN COMPUESTO DE POLISACARIDO LINEAL COMO HIALURONATO DE SODIO; POR LO MENOS UNO DE LOS SIGUIENTES COMPONENTES: c)AGENTE MEJORADOR DE TONICIDAD; d)REGULADOR DEL pH; e)CONSERVADOR TAL COMO CLORURO DE BENZALCONIO; f)UN PRODUCTO DE REACCION DE ACEITES NATURALES O HIDROGENAODS Y ETILENGLICOL COMO SOLUBILIZANTE, EN PARTICULAR OCTILFENOXI-POLI(ETILENOXI)ETANOL; g)AGENTE FORMADOR DE COMPLEJO; Y/O h) VEHICULO OFTALMICO. DONDE, LA VISCOSIDAD DE LA COMPOSICION ES DE 500 mPa A 2 000 mPa ENTRE 20°C Y 25°C, LA CUAL TIENE APLICACION EN EL TRATAMIENTO DE ENFERMEDADES/DESORDENES OFTALMICOS COMO: GLAUCOMA, MIOSIS, ANESTESIA O INFECCIONES OCASIONADAS POR VIRUS O MICROORGANISMOS; ASI COMO EN LA PREVENCION Y TRATAMIENTO DE CONJUNTIVITIS ALERGICA
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01113959 | 2001-06-08 | ||
| EP01113958 | 2001-06-08 | ||
| EP01115097 | 2001-06-21 | ||
| EP01115096 | 2001-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030206A1 true PE20030206A1 (es) | 2003-04-09 |
Family
ID=27440131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000483A PE20030206A1 (es) | 2001-06-08 | 2002-06-07 | Composicion oftalmica |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1404370A2 (es) |
| JP (1) | JP2005508866A (es) |
| CN (1) | CN1514735A (es) |
| AR (1) | AR034371A1 (es) |
| AU (1) | AU2002314149A1 (es) |
| BR (1) | BR0210139A (es) |
| CA (1) | CA2449213A1 (es) |
| PE (1) | PE20030206A1 (es) |
| WO (1) | WO2002100437A2 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002100436A2 (en) * | 2001-06-08 | 2002-12-19 | Novartis Ag | Ophthalmic once-a-day composition |
| US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
| JP2004143155A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
| US20040137079A1 (en) * | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
| EP2404606A1 (en) * | 2003-08-21 | 2012-01-11 | Sucampo AG | Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
| US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| US20050101582A1 (en) * | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| BRPI0506983A (pt) | 2004-01-20 | 2007-07-03 | Allergan Inc | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico |
| US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
| DE102005035986B4 (de) * | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat |
| US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
| CN100408046C (zh) * | 2005-12-22 | 2008-08-06 | 涂家生 | 大环内酯类抗生素玻璃酸钠眼用传输系统 |
| US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
| WO2012047893A2 (en) * | 2010-10-04 | 2012-04-12 | Activbiotics Pharma, Llc | Use of rifazil and analogues thereof to treat ocular disorders |
| KR101412776B1 (ko) * | 2013-03-11 | 2014-07-01 | 가톨릭대학교 산학협력단 | 각결막염 치료용 점안제 조성물 및 이의 제조 방법 |
| US9320709B2 (en) | 2013-08-28 | 2016-04-26 | Presbyopia Therapies Llc | Storage stable compositions and methods for the treatment of refractive errors of the eye |
| US10307408B2 (en) | 2013-08-28 | 2019-06-04 | Presbyopia Therapies, LLC | Contact lens compositions and methods for the treatment of presbyopia |
| US9833441B2 (en) | 2013-08-28 | 2017-12-05 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9314427B2 (en) | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
| US10617763B2 (en) | 2013-08-28 | 2020-04-14 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
| US9968594B2 (en) | 2013-08-28 | 2018-05-15 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9089562B2 (en) * | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US11179327B2 (en) | 2013-08-28 | 2021-11-23 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
| US10064818B2 (en) | 2013-08-28 | 2018-09-04 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
| US9844537B2 (en) | 2013-08-28 | 2017-12-19 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| AU2017311636B2 (en) | 2016-08-19 | 2023-08-10 | Orasis Pharmaceuticals Ltd. | Ophthalmic pharmaceutical compositions and uses relating thereto |
| US11648247B1 (en) | 2021-12-16 | 2023-05-16 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| RU2089191C1 (ru) * | 1994-01-28 | 1997-09-10 | Научно-производственная фирма "Нарт" | Способ пролонгирования физиологического эффекта тимолола снижать внутриглазное давление |
| CA2193149C (en) * | 1995-12-22 | 2002-04-23 | David H. Donabedian | Cationic therapuetic agents and delivery systems |
| JPH1160505A (ja) * | 1997-05-20 | 1999-03-02 | Senju Pharmaceut Co Ltd | 防腐組成物 |
| DE19923829A1 (de) * | 1999-05-17 | 2000-11-23 | Ulrich Kluegel | Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung |
| US6777429B1 (en) * | 1999-07-23 | 2004-08-17 | Novartis Ag | Ophthalmic composition |
-
2002
- 2002-06-06 AR ARP020102106A patent/AR034371A1/es unknown
- 2002-06-07 EP EP02740697A patent/EP1404370A2/en not_active Withdrawn
- 2002-06-07 BR BR0210139-4A patent/BR0210139A/pt not_active Application Discontinuation
- 2002-06-07 CA CA002449213A patent/CA2449213A1/en not_active Abandoned
- 2002-06-07 PE PE2002000483A patent/PE20030206A1/es not_active Application Discontinuation
- 2002-06-07 CN CNA028115317A patent/CN1514735A/zh active Pending
- 2002-06-07 AU AU2002314149A patent/AU2002314149A1/en not_active Abandoned
- 2002-06-07 JP JP2003503256A patent/JP2005508866A/ja active Pending
- 2002-06-07 WO PCT/EP2002/006279 patent/WO2002100437A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1404370A2 (en) | 2004-04-07 |
| AR034371A1 (es) | 2004-02-18 |
| CA2449213A1 (en) | 2002-12-19 |
| JP2005508866A (ja) | 2005-04-07 |
| WO2002100437A2 (en) | 2002-12-19 |
| CN1514735A (zh) | 2004-07-21 |
| AU2002314149A1 (en) | 2002-12-23 |
| BR0210139A (pt) | 2004-06-08 |
| WO2002100437A3 (en) | 2003-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030206A1 (es) | Composicion oftalmica | |
| JP5244584B2 (ja) | キサンタンガムおよびブドウ糖を含有する眼科用組成物 | |
| TW200700070A (en) | Enhanced bimatoprost ophthalmic solution | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| EA200700109A1 (ru) | Способы лечения офтальмологических состояний (варианты) | |
| KR101690817B1 (ko) | 안과용 조성물 | |
| AR064420A1 (es) | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). | |
| BR0310047A (pt) | Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular | |
| WO2016020526A1 (en) | Indoles for use in influenza virus infection | |
| AR036044A1 (es) | Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma | |
| CN103068364B (zh) | 不含防腐剂的比马前列素和噻吗洛尔溶液 | |
| KR101322527B1 (ko) | 잔탄 검 및 테르페노이드를 포함하는 점안제 | |
| AR032138A1 (es) | Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma | |
| Nepp et al. | The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome | |
| JP2021107464A (ja) | 眼科組成物 | |
| MX2022012575A (es) | Compuestos para usarse para tratar la enfermedad de huntington. | |
| CY1110644T1 (el) | 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις | |
| JP6921757B2 (ja) | 眼科組成物 | |
| BR0213325A (pt) | Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìda para a redução de dano isquêmico | |
| JP5419518B2 (ja) | アズレン誘導体含有液剤 | |
| CO2020009992A2 (es) | Composiciones oftálmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificación | |
| JP2010006796A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 | |
| JP4849288B2 (ja) | 点眼剤及び涙液膜の安定化剤 | |
| MX2023006652A (es) | Derivados de amina-indol-3-ciclica como agentes serotonergicos para el tratamiento de trastornos del snc. | |
| KR960700711A (ko) | 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |